In a major development, Sun Pharmaceutical Industries Limited., which includes “Sun Pharma” and their subsidiaries and/or associate companies) announced that they have launched FluGuard® (Favipiravir 200 mg) at an economical price of Rs. 35 per tablet, for the treatment of mild to moderate cases of Covid-19 in India, says a press release published on their website.
Favipiravir is the only oral anti-viral treatment approved in India for the potential treatment of patients with mild to moderate...
https://mfame.guru/first-oral-covid19-drug-becomes-cheapest-corona-treatment/